Modifiers of CAG repeat instability: insights from mammalian models by Wheeler, Vanessa & Dion, Vincent
1 
 
Modifiers of CAG Repeat instability: insights from mammalian models  
Vanessa C Wheeler1,2* and Vincent Dion3*  
 
 
*Corresponding authors and equal contributors 
 
1 Molecular Neurogenetics Unit, Center for Genomic Medicine 
Massachusetts General Hospital 
Boston, MA 02114, USA 
2 Department of Neurology 
Harvard Medical School 
Boston, MA 02115, USA 
wheeler@helix.mgh.harvard.edu 
 
3 UK Dementia Research Institute at Cardiff University 
Hadyn Ellis Building 
Maindy Road 
CF24 4HQ, Cardiff 
United Kingdom. 
Dionv@cardiff.ac.uk 
 
Key words: Huntington’s disease, myotonic dystrophy 1, DNA repair, trinucleotide 
repeat instability, mismatch repair. 
 
 
2 
 
 
Abstract 
At thirteen different genomic locations, the expansion of a CAG/CTG repeat causes 
a neurodegenerative or neuromuscular disease, the most common being 
Huntington’s disease and myotonic dystrophy type 1. These disorders are 
characterized by germline and somatic instability of the causative CAG/CTG repeat 
mutations. Repeat lengthening, or expansion, in the germline leads to an earlier age 
of onset or more severe symptoms in the next generation. In somatic cells, repeat 
expansion is thought to precipitate the rate of disease. The mechanisms underlying 
repeat instability are not well understood. Here we review the mammalian model 
systems that have been used to study CAG/CTG repeat instability, and the modifiers 
identified in these systems. Mouse models have demonstrated prominent roles for 
proteins in the mismatch repair pathway as critical drivers of CAG/CTG instability, 
which is also suggested by recent genome-wide association studies in humans. We 
draw attention to a network of connections between modifiers identified across 
several systems that might indicate pathway crosstalk in the context of repeat 
instability, and which could provide hypotheses for further validation or discovery. 
Overall, the data indicate that repeat dynamics might be modulated by altering the 
levels of DNA metabolic proteins, their regulation, their interaction with chromatin, or 
by direct perturbation of the repeat tract. Applying novel methodologies and 
technologies to this exciting area of research will be needed to gain deeper 
mechanistic insight that can be harnessed for therapies aimed at preventing repeat 
expansion or promoting repeat contraction.   
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Introduction 
 
The first discoveries in the 1990s that inherited unstable trinucleotide repeats caused 
human neurological and neuromuscular diseases stimulated considerable early 
interest in understanding the mechanisms underlying repeat instability (see [1] for a 
historical perspective). These so-called repeat expansion disorders exhibit instability 
of the expanded repeat tract upon transmission to the next generation as well as 
instability in somatic cells  [2–30]. To study mechanisms of repeat instability, a wide 
variety of model systems in different organisms, from E. coli to mice, have been 
implemented. In particular, a large body of research on repeat instability has been 
conducted in S. cerevisiae [31–35] and has guided many of the subsequent 
mammalian studies. Collectively across all organisms, many genes and candidate 
pathways have been identified that can play a role in altering repeat dynamics in the 
various model systems. Much less well understood is the relevance of most of these 
genes and pathways to human disease, as most have not been studied in the 
context of relevant cell-types in animal models or have no direct validation in 
patients.  
Here we review the modifiers and potential mechanisms underlying the 
instability of CAG/CTG repeats, gleaned primarily from mammalian cell-based and 
animal models, and put these observations into the context of recent human genetic 
data. We focus on the coding CAG repeat causing Huntington’s disease (HD) (OMIM 
#143100) and the non-coding CTG repeat causing myotonic dystrophy type 1 (DM1) 
(OMIM# 160900). These are the most common of the thirteen CAG/CTG repeat 
expansion disorders [22], upon which the majority of the mouse and patient cell-
based models are based.  
The HD CAG repeat is located within exon 1 of the HTT gene. CAG repeat 
lengths of 6-35 are not clearly disease-associated, whereas 36-39 CAGs and 40+ 
CAGs are associated with incompletely or fully penetrant disease, respectively 
[3,36]. A rarer juvenile-onset form of the disease is usually associated with >~60 
CAGs [37]. Intergenerational changes in repeat length, associated in males with 
instability in sperm DNA, are seen in the disease range (36+ CAGs) as well as in the 
high normal range (27-35 CAGs), the latter giving rise to new mutations [26,38]. 
Somatic instability has been studied in individuals with disease-associated repeat 
lengths. The instability in somatic cells is expansion-biased, occurs in both in the 
brain and in peripheral tissues, but shows tissue- and cell-type specificity; forebrain 
regions show relatively high levels of expansion, the cerebellum exhibits low levels of 
expansion, and neurons have greater expansions than glia [2,29,30]. Of the 
peripheral tissues, liver is relatively unstable [2]. Somatic expansion in postmortem 
cortex was found to be inversely correlated with the age of disease onset [4].   
The DM1 CTG repeat is located within the 3’ untranslated region (UTR) of the 
DMPK gene. Individuals are classified into five categories based on the age at onset: 
congenital, infantile, juvenile, adult, and late-onset [39,40]. These are largely 
correlated with repeat size, but there is significant overlap between the categories 
[41]. Repeat lengths of 5-~37 CTGs occur in the general population, and it is thought 
that alleles between 16 and 30 repeats are the source of rare de novo expansions 
[42]. Affected individuals can harbor from ~50 to several thousand repeats, with 
congenital DM1 often presenting with alleles >1,000 CTGs [43,44], Repeats of ~50-
79 exhibit high levels of male germline expansion, whereas 80+ repeats tend to 
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exhibit greater expansions in female transmissions [41]. Somatic instability can be 
detected in fetal tissues between 13 and 16 weeks of gestation, and in patients 
shows expansion-biased and tissue-dependent instability, with high levels seen in 
heart, skin, muscle and blood, as well as in brain tissues [41,45].  
Thus, patient data indicate that there may be differences in mechanisms of 
instability in HD and DM1, likely due to genomic location and repeat length. 
However, as revealed by studies in mice there are clearly shared underlying 
mechanisms. Thus, observations in DM1 models may well be relevant in HD where 
the CAG repeat can expand somatically to hundreds of repeats [4,29]. The reverse is 
also true: the observations made in HD models are likely to be relevant to DM1, in 
particular for repeat lengths in the lower range. Overlapping mechanisms extend to 
other trinucleotide repeats, as discussed in [46]. Equally important however, are 
aspects of repeat instability and modifiers that distinguish the different disease-
associated repeats that may yield important mechanistic insight.  
As described in the following sections, many genes that function in DNA 
repair pathways have been found to modify CAG/CTG instability. In several cases 
(see: “Non-canonical mechanisms underlying repeat instability?”) it appears that 
the encoded proteins do not in fact “repair” DNA, but rather promote mutation. For 
the purpose of this review, we use the term “DNA repair” to describe the process or 
function to which genes or pathways are traditionally assigned, rather than the 
functional outcome of that process in the context of expanded repeats. More 
specifically, and as an example, we use the term “mismatch repair” (MMR) to mean 
the canonical post-replicative pathway and its components [47], acknowledging that 
the specific functions of the proteins in the pathway may be different in the context of 
expanded repeats.  
 
 
The link with human genetic studies 
 
An ongoing challenge is to understand which of the many modifiers identified in 
model systems is relevant in humans. Recent genome-wide association studies 
(GWAS) for modifiers of onset in HD have identified genes in the mismatch repair 
(MMR) pathway (MSH3, MLH1, PMS2, PMS1) as modifiers of the rate of disease 
onset in patients [48–51]. MSH3, also modified a measure of HD progression [52]. 
Other DNA repair genes identified in the age-at-onset GWAS were LIG1, encoding a 
DNA ligase that can function in several DNA repair pathways, and FAN1, encoding 
FANCD2 and FANCI Associated Nuclease 1, with a role in repairing interstrand 
crosslinks. Several MMR pathway genes had been previously identified as critical 
drivers of somatic repeat expansion in mouse models (see below), thus providing 
strong support for somatic expansion as the underlying mechanism for disease 
modification in HD. Notably, the genes that have emerged in the human genetic 
studies to date do not obviously highlight a role for a general DNA damage response 
as a driver of disease onset, where key players include ATM and ATR for example 
[53]. Interestingly, two HD onset-modifying DNA repair genes, FAN1 and PMS2, 
were also associated with age at onset in the spinocerebellar ataxias (SCAs), 
caused by CAG expansion mutations but having distinct neuropathological profiles 
[54], suggesting somatic expansion as common disease onset-modifying 
mechanism. MMR pathway genes MSH3, MLH1 and MLH3, as well as FAN1, are 
also associated with repeat instability in HD or DM1 patient blood [50,55–57].  
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Human genetic discovery efforts help to define the DNA repair factors and 
pathways that may play prominent roles in the process of somatic repeat expansion 
in cell-types that are relevant to the onset or progression of disease phenotypes, 
prioritizing targets for therapeutic intervention [58]. Larger sample sizes would be 
expected to reveal genetic modifiers that are rarer in the population and/or that have 
weaker effects. However, the absence or rarity of naturally occurring functional 
variation in a particular gene will preclude its detection in genetic association studies. 
Therefore, complementary investigation of instability in model systems allows the 
identification of modifier genes that may not be revealed in human genetic studies, 
but which may be part of the same pathway(s), better defining pathways and 
mechanisms and providing additional points for possible therapeutic intervention. An 
example is MMR pathway gene MSH2; this gene has not emerged as a human 
onset modifier, yet it is clearly required for somatic expansion in mouse models as 
well as in patient cell-based models (Table 1). This may indicate the lack of 
functional MSH2 variation in the human population at sufficiently high frequency to 
be detected in the GWAS studies to date.  
 
Non-canonical mechanisms underlying repeat instability? 
 
The underlying mechanisms by which DNA repair proteins modulate repeat 
instability remain to be clearly defined. However, it is conceivable that these proteins 
could act in non-canonical ways or in non-canonical pathways. DNA repair pathways 
are traditionally defined based on the repair of a specific lesion, such as a mismatch 
or a single-strand break. However, the substrate(s) or lesion(s) at repeat tracts may 
be highly unusual, and the classical definition of DNA repair pathways may break 
down. Therefore, it is plausible that DNA repair proteins have roles promoting or 
protecting against repeat instability that differ from those usually described during the 
repair of a specific lesion. Most notably, the same MMR proteins that normally act to 
suppress genomic instability by repairing post-replicative errors, promote CAG/CTG 
instability in non-dividing cells. This counterintuitive finding suggests that repeat 
tracts might engage components of the MMR machinery in unusual ways, and/or 
could implicate other pro-mutagenic processes in which MMR factors play roles 
[59,60]. There is also considerable cross-talk between proteins in DNA repair 
pathways (see non-exhaustive examples in these reviews:[61–65]). Thus, DNA 
repair proteins may work together in unexpected ways to modulate repeat dynamics. 
For example, FAN1 is not a component of the classically-defined MMR pathway, yet 
Fan1 interacts genetically with Mlh1 to control somatic CAG instability in mice [66].  
Although it remains helpful to broadly classify modifiers of repeat instability by 
the pathways in which they were first described, as categorized below and illustrated 
in Figure 1, we also present genetic modifiers identified in the various mammalian 
model systems in the context of known associations between them, in a manner that 
is agnostic to their classically defined functions (Figure 2). This allows a better 
appreciation of the extent to which many of the modifiers (Table 1), regardless of the 
system(s) in which they were identified or their specific role in modifying repeat 
instability, are connected as part of a network. Importantly however, the vast majority 
of these genes have not been validated as modifiers of repeat instability in mouse 
models, and/or their relevance to patients is unknown (see color coding in Figure 2). 
The connections in this network may therefore provide testable hypotheses for future 
discovery of genes and pathways that might be relevant to repeat instability in 
disease.   
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Type of model/method to detect 
instability 
CAG/CTG repeat substrate 
Normal Gene function 
References enhances 
contractions 
suppresses 
contractions 
enhances 
expansions 
suppresses 
expansions 
No effect 
found 
Integrated chromosomal selectable 
reporter. Only detects large 
contractions 
(CAG)~95 including 19 nt 5’ and 43 nt 
3’ flanking DMPK  sequence in intron 
1 of HPRT [67]. 
 
BARD1, BRCA1, 
CSB, ERCC1, 
MSH2, MSH3, TFIIS, 
XPA, XPG. 
DNMT1, HSP90, 
MLH1, PARP1, 
PMS2, 
RAD51, RNASEH1, 
RNASEH2a, TOP1, 
TDP1, XRCC1. 
  
APEX1, FEN1, 
MLH3, 
MSH6, OGG1, 
XPC. 
[67–73] 
 
Shuttle vectors using human cells 
and reporter in S. cerevisiae. Only 
detects expansions. 
(CTG)22 5’ of S. cerevisiae CAN1 
ATG or of URA3 ATG 
  
HDAC3, HDAC5, 
@MSH3, MSH2, 
PSMB3, PSMC5. 
CBP, EP300, 
HDAC9, HLTF, 
RAD18, 
RTEL1. 
CTIP, DSS1, 
FBH1, 
HDAC1, 
MRE11, 
MSH6, 
SHPRH. 
[74–78] 
 
Ectopic loci in human cell lines: 
direct detection by PCR 
(CTG)~800 in DMPK 3’ UTR [79]; 
(CTG)~102 or (CAG)~102 adjacent to 
Myc replication origin [80,81]; HTT 
exon1 with (CAG)~118 [82] 
MSH2, MSH3, TFIIS. 
CLSPN, FEN1§, 
SETX, TIMELESS, 
TIPIN 
*TOP1+TDP1. 
MSH2, MSH3, 
TFIIS. 
FAN1, MSH6. 
MLH1, PMS2, 
*TOP1, 
*TDP1. 
[79–82] 
Endogenous loci in patient-derived 
cells: 
direct detection by PCR 
DMPK (CTG)~400-1000 [80]; DMPK 
(CTG)~773 [83]; HTT (CAG)~109 [82]; 
(CAG)~72 [84] 
 
CLSPN, TIMELESS, 
TIPIN. 
MSH2. FAN1.  [80,82–84] 
Knock-in and transgenic mice: direct 
detection by PCR 
Htt CAG knock-in mice: 
HttQ111:(CAG)~120 
HttQ150:(CAG)~150 
HttQ50 and HttneoQ50:(CAG)48 
 Msh2, Msh6. 
Hdac2, Hdac3, 
Msh2, Msh3, Mlh1, 
Mlh3, Ogg1. 
Fan1 Xpc, Aif, Dat [66,85–91] 
R6/1 HTT exon 1 transgenic mice: 
(CAG)~120 
Csb#. Fen1. 
Msh3, Ogg1, Neil1, 
Fen1. 
Csb#. 
Msh6, Aag1, 
Nht1. 
[92–101] 
Dmpk CTG knock-in mice: (CTG)~84   Msh3. Msh6. Fen1. [102,103] 
DMPK transgenic mice: 
DM300-328: (CTG)>300 
Dmt-D: (CTG)~160 
 
Msh2, Msh3, Msh6† 
Lig1†. 
Msh2, Msh3, 
Msh6&, Pms2, 
Lig1†, Rad52&. 
 
Msh6, Rad54, 
DNAPKcs. 
[104–107] 
Atxn1 CAG knock-in mice: 
(CAG)~145 
Dnmt1&.  Xpa.  Dnmt1&. [70,108] 
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Table 1: Genetic modifiers of repeat instability found in mammalian systems: Excluded from this list: 
modifiers that act in the context of an exogenous perturbagen or sensitizer (e.g. under replication 
stress, or upon double-strand break or nicks induced within the repeat tract). @ No effect of MSH3 
knockout on contractions in a (CTG)33-URA3 shuttle vector assay that detects contractions only [78].* 
Effect only seen with simultaneous knockdown of both TOP1 and TDP1. # In male germline 
transmissions only; in somatic cells, effect only seen with simultaneous knockout of both Csb and 
Ogg1. § Depends on the orientation of the repeat tract with respect to the origin of replication. & only 
for intergenerational transmissions.  only in male germline transmissions. † only during maternal 
germline transmissions. HttQ111, HttQ50, HttneoQ50and R6/1 mice have a canonical human 
(CAG)nCAACAG repeat structure; HttQ150 mice do not have a penultimate CAACAG. Note that the 
mouse knock-in models are also referred to using the original gene nomenclature as HdhQ111, HdhQ50, 
HdhneoQ50 and HdhQ150.  
 
 
Figure 1: Classically defined DNA repair pathways implicated in repeat instability. Outline of four 
different repair pathways, indicating a non-exhaustive list of proteins within those pathways, either 
based on in vivo evidence or from reconstituted systems. Modifiers of repeat instability are color-
coded as follow: purple: modifier of repeat instability in murine models; pink: modifier with contested 
or unclear somatic instability data; blue: modifiers in non-murine models; brown: modifier in 
biochemical assays; orange: no effect when tested in a mammalian system; black: not tested for an 
effect on repeat instability. See Table 1 for direction of effect of modifiers in mammalian systems. 
Figure update from [109] with permission.  
 
Mammalian models used to study CAG instability 
The principal types of cell or animal-based mammalian model systems and assays 
that have been developed to investigate CAG/CTG instability, are summarized in 
Table 1 and in Figure 3. Knock-in and transgenic mice have been generated with 
unstable repeats, typically containing more than 100 units [110]. Repeat instability is 
analyzed in these models by PCR, using either small pool-PCR with Southern blot 
detection, or using fragment analysis on a DNA sequencer [13,87]. These models 
exhibit repeat length-and time-dependent, expansion-biased somatic instability that 
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is tissue or cell type-specific [87,89,102,111–117]. In the HD models, high levels of 
expansion are seen in the striatum, in particular in the medium-spiny striatal neurons 
(MSNs), and in the liver, attributable to hepatocytes [87,89,102,116,117]. The 
cerebellum exhibits relative stability [87,116]. Overall, there is very good correlation 
with tissue-specific instability patterns observed in both adult and juvenile onset HD 
[2]. DM1 mouse models can exhibit relatively high instability in kidney, liver, skeletal 
muscle and brain, including the striatum, with relatively low instability in the spleen, 
heart and cerebellum [112,115,118]. There appears to be more variation in the 
tissue-specific instability patterns between different DM1 lines than apparent across 
HD mouse models, and in general, extensive comparisons with human have been 
limited by the lack of availability of human tissues. Both HD and DM1 models exhibit 
intergenerational repeat length changes that recapitulate some, but not all of the 
features of intergenerational instability in patients. A paternal expansion bias is seen 
in transmissions in HD and DM1 models [112,113,119] with maternal expansions in 
DM1 depending on the model [112,119]. However, absolute mutation rates are much 
lower than those seen in patients, requiring very long CAG lengths relative to those 
in humans, to achieve frequencies of intergenerational changes and/or large jumps 
in repeat size that are seen in patients [112,120,121]. Thus, parallels in many of the 
features of repeat instability in patients and in mice indicate that the mice models are 
likely to afford insight into mechanisms of instability that are relevant to disease in 
patients. Other advantages of mouse models are that they allow the dissection of 
modifiers that might act in a tissue/cell type-specific manner, including distinguishing 
mechanisms that act in the germline and in the soma. They also permit the analysis 
of naturally occurring strain-specific variation that is associated with different levels 
of instability [90,94,117,121,122]. Moreover, comparisons between models that differ 
in repeat length and genomic contexts can provide information on the role of cis 
elements that might contribute to repeat instability [111,115,119,121,123–125]. While 
yielding rich in vivo insights into potential mechanisms of repeat instability, the 
throughput in mice is low due to the need for extensive breeding to test genetic 
modifiers, and the time (several weeks to months) for somatic repeat expansions to 
accumulate. This is especially challenging in models with shorter inherited repeat 
lengths, e.g., within the adult-onset range of CAG lengths for HD (~40-50); although 
these models would better model the typical time-course of somatic expansion seen 
in most HD patients, the relatively slow rate of somatic expansion and the limited 
extent of expansion within the lifespan of a mouse [66] may make some modifier 
studies impractical. Finally, the ability to query a particular genetic modifier will 
depend on germ cell or mouse viability when the gene is knocked out or mutated.  
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Figure 2: Network of repeat instability modifiers. This network was generated using StringDB v.11. 
The thickness of the edges refers to the confidence score (CS). 1 pt edges represent a CS of 0.7, 2 pt 
edges have a CS of 0.8, and 3 pt edges have a CS of 0.9 or greater. The String output categorizes 
interactions as “binding” (direct or indirect), “catalysis” and “reaction”: for clarity we have not included 
this in the Figure, but refer the reader to the StringDB v.11 for this information [126]. Purple nodes are 
genetic modifiers in at least one mammalian system for studying repeat instability. Green nodes are 
modifiers of repeat instability in murine models of CAG/CTG diseases. Names of genes additionally 
identified as modifiers of HD age at onset or progression [48–50,52] are highlighted in red font. PMS1 
promotes repeat expansion in a mouse cell model with an expanded CGG/CCG repeat [127]. 
 
At the other end of the spectrum are systems in cultured human and primate 
cells, either utilizing plasmid-based mammalian-E. coli / S. cerevisiae shuttle vectors, 
or chromosomally-integrated reporters (Figure 3). In the shuttle vector systems, 
CAG/CTG-containing plasmids are first introduced into mammalian cells and, 
following the experimental perturbation, are transformed into E. coli or S. cerevisiae 
for read-outs of instability. In one system, which has been used extensively to test 
genetic modifiers repeat length changes can be determined in S. cerevisiae based 
upon a CAG length-dependent resistance to 5-fluorooritic acid (5-FOA) [128] or to 
canavanine [75]. In another system, repeat length changes are measured by 
digesting plasmids isolated from single E. coli colonies and run on high-resolution 
polyacrylamide gels [129]. Shuttle vector systems have the major advantage of 
requiring only a few days. Integrated chromosomal reporters have been developed 
based on a CAG length-dependent sensitive hypoxanthine-guanine 
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phosphoribosyltransferase (HPRT) or adenine phosphoribosyltransferase (APRT) 
activity, which can be selected in the appropriate culture media, or based on CAG 
length-dependent GFP fluorescence.  These chromosomal reporter systems require 
a longer time for read-outs of instability compared to shuttle vectors but offer a 
higher throughput [67–73,130–135]. Notably, the largest small molecule screen 
conducted so far was performed using a selectable chromosomal reporter system 
and included 880 compounds [72]. The use of selectable markers, in the context of 
either the shuttle vector or integrated reporter assays allows for the sensitive 
detection of low frequency instability events, and the ease of combining both of these 
systems with knockdown, and more recently knockouts, has greatly facilitated the 
dissection of DNA repair pathways that are involved in CAG/CTG instability in 
cultured mammalian cells. [69,72,74–76]. The disadvantages of these systems are 
that they work in immortalized and rapidly dividing cells, they probe the instability of 
repeats outside of their endogenous genomic loci, they detect rare events, and are 
only sensitive to specific types of repeat length changes that can be selected for in 
the respective assays. For example, the chromosomal reporter systems based on a 
(CAG)95 repeat in an intron of the HPRT gene or the APRT gene is only sensitive to 
large repeat contractions that bring the repeat size below a threshold of ~38 repeats, 
which is required to restore HPRT or APRT function [132]. Conversely, the human 
astrocyte cell line (SVG-A)/S. cerevisiae shuttle vector system is only sensitive to 
expansion of a (CTG)22 track to 29 or more repeats or more, which alters 
transcription initiation and blocks expression of the CAN1 or URA3 reporter [75,128]. 
Therefore, these systems are unlikely to recapitulate fully what occurs in disease-
relevant cell types. Use of a green fluorescent protein (GFP) reporter mitigates one 
of these issues by enabling the simultaneous read-out of both expansions and 
contractions while still providing an assay system that is compatible with high 
throughput screening [130,133,134].  
 Other mammalian cell-based systems are those in which repeats are detected 
directly by PCR, allowing monitoring of both expansions and contractions that occur 
at relatively high frequencies. These include cell lines stably transfected with 
plasmids harboring expanded repeats at ectopic loci [79–82], those derived from 
mouse models [87,136] or from patient-derived cells including lymphoblastoid cell 
lines and fibroblasts [80,137–139], embryonic stem cells [140,141], and induced 
pluripotent stem cells (iPSCs) [82–84]. Pluripotent cells have the major advantage of 
having the potential to differentiate into many different cell types. In practice, 
differentiation protocols can often yield a variable fraction of the intended cell type. 
Modeling repeat instability in patient cells has the advantage of providing direct 
insight into human-relevant modifiers of instability of repeats in their appropriate 
genomic contexts. However, these – and all patient-derived cell models – are slow, 
typically requiring long-term culturing of weeks to months to observe measurable 
instability. Dividing cells may also introduce selection or clonal artefacts that need to 
be considered [136,142]. Differentiating stem cells into specific cell types found to 
exhibit high levels of instability in mice and patients, e.g. MSNs, may increase the 
rate of repeat expansion in cultured cells. However, improved differentiation 
protocols are needed to increase the purity of the desired cell type. Human 
organoids have not yet been used for the study of repeat instability, but have the 
potential to model complex tissue environments in the context of human mutations 
[143].  
Despite the disadvantages inherent to all these systems and approaches, 
each has yielded important insights into modifiers of CAG/CTG instability, 
contributing to our understanding of potential underlying mechanisms. Many factors, 
particularly MMR genes, modulate instability across multiple systems, indicating the 
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value of initial high-throughput systems as screening tools to generate candidates for 
testing in mice or human cells (Table 1).  
 
 
Figure 3: Common assays for measuring repeat instability. Direct detection of repeat length changes 
is used to analyze instability in mouse models, patient-derived cells and cell-based models harboring 
repeat tracts at ectopic loci. Small-pool PCR is the current gold standard as it reduces bias against 
amplification of longer alleles, it is quantifiable, and can detect both expansions and contractions. It is 
prone to carry-over contamination and is time-consuming. Recently published methods address those 
concerns [144,145]. Fragment analysis, e.g. using GeneMapper [111] is quicker and easier than the 
small-pool PCR, is not as sensitive to rare events but is also quantitative [87]. Methods for studying 
repeat instability are discussed in detail in [146].  A shuttle vector assay in which repeat length 
changes are detected directly has been used for mapping cis-acting elements, including origin of 
replication distance and direction as well as DNA methylation [129,147]. It has not been used in 
conjunction with genetic perturbation. Shuttle vector assays using selectable reporters were first 
developed as a unidirectional contraction assay [148,149] and later as an expansion-only assay 
[75,128]. Two versions of the latter exist, one using the S. cerevisiae CAN1 gene, the other the URA3 
gene. The CAN1 reporter assay has been extensively used for genetic studies (see Table 1). 
Integrated chromosomal reporters have the advantage of being ultra-sensitive, but limited in the types 
of events they can detect. The first ones relied on APRT and HPRT function. An expansion assay was 
developed but was found to have impractically low frequencies of expansions [150]. The expression 
can be controlled with a doxycycline-inducible promoter [67]. HAT: medium containing hypoxanthine 
aminopterin and thymidine. An integrated chromosomal reporter based on GFP fluorescence can 
detect both expansion and contractions, but has not yet been used to uncover genetic modifiers 
[130,133].  
 
Mismatch Repair Factors 
 
The MMR pathway is best characterized for its role in correcting DNA mismatches 
generated during DNA replication but has additional functions in DNA recombination 
and in DNA damage signaling (reviewed in [47,151,152]). In mammals, MSH2-MSH6 
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dimers (MutSα) primarily recognize base-base mismatches, whereas MSH2-MSH3 
dimers (MutSβ) primarily recognize insertion-deletion loops. During the process of 
MMR, DNA recognition is followed by binding of MLH1-PMS2 (MutLα) that mediates 
the recruitment of downstream effector proteins to excise and repair the lesion. Two 
additional MutL dimers have been described: MLH1-MLH3 (MutLγ) plays a role in 
meiosis, whereas the role of MLH1-PMS1 (MutLβ) is yet unclear. Mutations in 
MSH2, MSH6, MLH1 and PMS2 underly the cancer prone Lynch syndrome in which 
biallelic mutations result in elevated instability of microsatellite repeat tracts [153]. 
This observation prompted an early interest in the role of MMR factors in the 
instability of disease-associated trinucleotide repeats.  
A role for MMR pathway genes in CAG instability in an animal model of 
disease was first demonstrated by Manley et al., in which genetic knockout of Msh2 
eliminated somatic HTT CAG expansion in R6/1 exon 1 HD transgenic mice [97]. 
Constitutive, or striatal MSN-specific, Msh2 knockout in HttQ111 HD knock-in mice 
abrogated CAG expansion in the striatum [86,88,89], demonstrating that MSNs 
harbored the most highly expanded alleles and that a process dependent on a MMR 
gene driving CAG expansion was active in post-mitotic neurons. Knockout of Msh2 
also suppressed male gametic expansion [98] and inherited repeat length changes in 
paternal transmissions [86,88]. The absence of Msh2 promoted repeat contraction in 
paternal transmissions [86,88], indicating a distinct role for MSH2 in protecting 
against CAG contractions. Similarly, in a DM1 transgenic mouse model harboring a 
long (>300 CTG) repeat tract (DM300-328), Msh2 knockout suppressed expansions 
and enhanced contractions in both the soma and the germline [106].   
Genetic knockout of Msh3 in multiple knock-in and transgenic models 
implicates MutSβ as the major driver of somatic CAG/CTG expansion 
[88,93,103,105]. In the germline, Msh3 knockout had a moderate impact relative to 
that of the Msh2 knockout in HttQ111 mice, but strongly suppressed germline 
expansions in DM300-328 mice [88,105]. Msh3 knockout also promoted contractions 
in DM300-328 mice, indicating a contraction-suppressor role for MutSβ [105]. In a 
cell-free SV40 replication assay MutSβ also protected against contractions [154], 
with the suggestion that a contraction-suppressor role may be relevant to dividing 
cells in vivo. The contrasts between the HttQ111 and DM300-328 models suggest 
potential differences in MMR-related mechanisms in the soma and germline that 
might depend on the disease gene context and/or CAG/CTG repeat length. Notably, 
in both HD and DM1 models, heterozygous Msh3 knockout was sufficient to reduce 
CAG/CTG expansion, indicating that MSH3 levels are rate limiting in the expansion 
mechanism [88,105]. Consistent with this, Msh3 expression levels correlated with 
CAG expansion in mouse strains harboring naturally occurring Msh3 variants [94] 
and in a human SVG-A astrocyte cell-based model [78]. The extent to which MSH3 
levels contribute to CAG expansion that differs between tissues or between cell 
types [30,83,87,140,155,156] is not well understood and warrants further 
investigation.   
The role of Msh6 is much less clear, with variable effects in mice depending 
on the model. In HttQ111 mice, Msh6 knockout had no impact on striatal expansions, 
whereas heterozygous knockout promoted contractions in the male germline [88]. In 
R6/1 mice, Msh6 knockout slightly reduced expansion in a tissue-specific manner 
[93]. In DM1 models, Msh6 knockout had either no impact [105] or promoted 
expansion [118] in somatic cells, and suppressed expansions and promoted 
contractions in the female germline [105]. Some of these effects may be attributable 
to altered levels of the MutSβ complex as a consequence of reduced MSH6 protein. 
However, this remains to be tested, and direct roles of MutSα are also possible. 
Overall the data indicate that although Msh6 is not a key driver of somatic CAG/CTG 
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expansion, it may modulate various aspects of repeat instability with the extent of its 
involvement perhaps depending in part on the relative levels of MSH6 and MSH3 in 
different cell types [157]. Cell-based systems, including reporter-based assays that 
exclusively detect either expansion or contraction events, have reinforced CAG/CTG 
instability-promoting roles of MSH2 and MSH3 observed in mice, whilst showing 
minimal impact of MSH6 [67,69,76,79,83]. 
In addition to Msh2 and Msh3, both Mlh1 and Mlh3 are absolutely required for 
somatic CAG expansion in HttQ111 mice [90], implicating MutLγ in this process. Pms2 
knockout partially reduced expansions in DM1 transgenic mice, also implicating 
MutL [104]. Naturally occurring strain-specific Mlh1 variation was associated with 
CAG expansion, an effect that could in part be explained by altered MLH1 
expression [90].  Both MutLα and MutLγ possess endonuclease activities that, in 
reconstituted systems, can result in the retention of CAG or CTG loop-outs, 
representing expansion events [158,159]. MutLα was also capable of eliminating 
such loop-outs in this system, representing potential contractions [158]. MutLγ 
endonuclease activity has been implicated in the expansion of GAA repeats [160]. 
Note that in cell-based systems, modifier roles of MutL genes were not found [79] or 
were inconsistent with observations in mice [69]. Importantly, the critical requirement 
for MutL genes for somatic expansion in mouse models supports the idea that active 
DNA repair is required to drive CAG/CTG expansion, rather than subversion of a 
normal MMR process (see below). This is also supported by data in mice indicating 
that the ATPase activity of MSH2, which is essential for the recruitment of MutL 
proteins, is required for repeat instability [95]. Similarly, an ATPase mutant in MSH3 
behaved like a knockout in a human cell system for repeat expansion [78]. 
Downstream MMR factors (exonucleases, polymerases, ligases) that are involved in 
repeat expansion have not been delineated. The identification of LIG1 as a human 
onset modifier [50], and the knowledge from reconstituted systems that this DNA 
ligase can function in MMR [161], suggests that it may be part of the MMR 
mechanism that drives somatic expansion. In mice, Lig1 heterozygosity leads to 
more expansions and fewer contractions exclusively in the female germline of DM1 
transgenic mice [107], and LIG1 expression levels were found to correlate with 
repeat instability in a cell-free replication assay [162]. Further studies on the role of 
LIG1 in somatic expansion are of interest.  
To gain insight into the mechanism by which MMR proteins promote 
expansion, several biochemical studies have also been conducted to understand the 
nature of the repeat substrate that can be bound by MutSβ and the consequences of 
repeat binding. Both short (1-3 repeat) loop-outs and longer CAG repeat-containing 
hairpin structures can bind MutSβ [93,163–166]. Some, but not all, of these studies 
indicated that CAG hairpins can alter properties of MutSβ binding or activity 
[93,164,166]. These observations have provided some controversy as to whether 
MutSβ binding to repeats inhibits the normal process of MMR. In cell-free assays 
that measure the repair of repeat-containing substrates, the repair of short loop-outs 
was found to be dependent on MutSβ and MutLα [163,167] and hairpin repair was 
stimulated by MutSβ [164]. Although these assays do not provide a direct readout of 
instability per se, these findings support the idea that MutSβ binding to repeat 
structures stimulates, rather than inhibits, a repair process that ultimately results in 
expansion, consistent with genetic data in mice.  Although CAG/CTG slipped-strand 
structures have been identified in patient tissues [168], and enrichment of MMR 
proteins can be observed close to CAG/CTG repeat tracts using chromatin 
immunoprecipitation [76,79,83,96,169], the nature of the substrate(s) bound by 
MutSβ in vivo remains unknown. Further studies are needed to tie biochemical 
observations to repeat instability outcomes.  
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FAN1: a protein involved in interstrand cross link repair 
 
FAN1 is required for the repair of interstrand DNA crosslinks (ICLs), possessing both 
5'-->3' exonuclease activity and a structure-specific endonuclease [170–174]. A 
potential role in CAG repeat instability was first indicated by human GWAS that 
identified FAN1 as a modifier of HD onset [49]. Subsequently, it was shown that 
FAN1 knockout in a human U2OS cell line model containing HTT exon 1 with 118 
CAGs, or FAN1 knockdown in HD patient iPSCs with ~109 CAGs or ~70 CAGs 
enhanced HTT CAG expansion [82,84]. Knockout of Fan1 also enhanced somatic 
CAG expansion in the striatum and other tissues of HttQ111 mice, in a manner that is 
dependent on Mlh1 [66]. Significantly, Fan1 knockout also promoted expansion of a 
48-CAG repeat tract in HD knock-in mice, indicating that FAN1 normally acts to 
suppress the expansion of CAG repeats that fall into both the adult-onset and 
juvenile-onset inherited length ranges of the human disease [66]. Notably, FAN1 
physically interacts with MLH1, MLH3, PMS1 and PMS2 [170,175]. The mechanism 
by which FAN1 normally suppresses CAG expansion, whether physical interaction(s) 
between FAN1 and MMR proteins are required in the process of CAG repeat 
instability and whether additional ICL proteins play a role in repeat instability are 
currently unknown.  
 
Base Excision repair and single strand break repair 
 
Base excision repair (BER) is initiated by the detection and excision of damaged 
bases in the DNA [176]. This is followed by the formation of an apurinic/apyrimidinic 
(AP) site that is cleaved by APEX1, which leaves a single base pair gap. DNA 
polymerase beta (POLβ) fills in the missing base pair for a short-patch BER followed 
by a ligation event or coordinates a long-patch synthesis that involves strand 
displacement and FEN1 activity in addition to DNA ligases (I and III). Single-strand 
break repair (SSBR) is often referred to as a sub pathway of BER [177–180] as it 
uses some of the same proteins, e.g., XRCC1, PARP1, and LIG1 (Figure 1).  
In the context of repeat instability, a chemical screen identified molecules 
targeting several enzymes in the SSBR pathway including topoisomerase 1, TDP1, 
and POLβ, to stimulate repeat contractions in a selectable assay [72]. Knockdown of 
TDP, TOP1 as well as other SSBR genes, including XRCC1 and PARP1, confirmed 
that SSBR protects against contractions [72]. It is unknown whether these factors 
influence expansions as well. In a different system with 800 CTG repeats inserted at 
an ectopic site, individual knockdown of TDP1 or TOP1, had no effect on repeat 
instability, though their simultaneous knockdown dramatically increased repeat 
contraction [79]. SSBR proteins have not been investigated beyond these two 
systems, but downstream factors in the SSBR pathway are shared with other 
pathways and several are involved in repeat instability (Figure 1), notably XRCC1 
and LIG1. 
Extensive studies have been carried out to understand the role played by the 
repair of oxidized bases in repeat instability.  Knockout of Ogg1, encoding a 
glycosylase that excises oxidized guanines from DNA, reduced somatic expansion in 
~70% of R6/1 mice [100], as well as in HttQ150 knock-in mice [85]. Kovtun et al. 
proposed a model [100] whereby 8-oxoguanine (8-oxoG) excision from within the 
repeat tract by OGG1 triggers error-prone repair, involving FEN1 and long-patch 
BER. This process then leads to expansion either by DNA polymerase slippage or 
because the secondary structure formed within the displaced flap prevents FEN1 
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action and is ligated in rather than digested [181]. It has been further suggested that 
the stoichiometry of FEN1 and POLβ and coordination between these proteins is 
important in determining the efficiency of gap-filling synthesis that would be expected 
to promote expansion [182–184]. Recent studies indicate that interaction between 
POLβ and MutSβ [185,186] also promotes gap-filling synthesis, suggesting cross-
talk between BER and MMR pathways [185]. However, a role for FEN1 that is 
predicted by this model, and previously shown in S. cerevisiae to protect against 
CAG/CTG instability, including expansions [187–189], has been more difficult to test 
directly in mice due to the lethality of the homozygous knockouts. Heterozygous 
Fen1 knockout had no impact on somatic CAG expansion in R6/1 mice [99] or in 
DM1 knock-in mice [103]. There is some evidence that Fen1 promotes expansions 
and suppresses contractions in the male germline [99] and suppresses contractions 
during DNA replication in a human cell-based model [81] but neither OGG1 nor 
FEN1 knockdown modified contraction frequency in a transcription-dependent 
chromosomal reporter assay [67,68]. The role of POLβ in CAG/CTG expansion in 
mice is unknown, though it was found to modify FMR1 CGG instability in a mouse 
model of Fragile X-related disorders [190].  
The idea that DNA repair triggered by oxidized bases leads to repeat 
instability is also supported by the observation that knockout of Neil1, encoding 
another glycosylase with a preference for oxidized pyrimidines and minimal activity 
towards 8-oxoG, reduced somatic expansion in R6/1 mice [92]. Oxidized bases or 
AP sites have also been implicated in CAG/CTG repeat instability in cell-free 
systems [191–196], supporting a role for oxidative damage triggering repair within a 
repeat tract. Interestingly, guanines are more susceptible to oxidation when in the 
loop of a hairpin, yet are inefficiently repaired [191,196], further supported by the 
CAG length-dependent accumulation of oxidative lesions within the CAG repeat tract 
in HD knock-in mice [183]. These data appear to present somewhat of a paradox 
inasmuch as they imply the lack of repair at repeat tracts, rather than the active 
repair of oxidized lesions. However, a model has been proposed in which oxidative 
lesions that arise transiently in susceptible hairpin structures may be inefficiently 
repaired and thus incorporated into the repeat [196]. It has also been suggested that 
oxidized bases themselves may be incorporated [192]. 
A key tenet of the models involving recognition of oxidized bases is a ”feed 
forward” toxic oxidation cycle whereby the accrual of oxidative lesions with aging and 
disease pathogenesis progressively increases the susceptibility of the repeat tract to 
error-prone repair [100], thus accelerating the rate of expansion. As the brain is 
highly susceptible to oxidative stress, and as there is evidence for the further 
accumulation of 8-oxoG in brains of R6/1 and R6/2 HD mice [100,192] as well as in 
HD post-mortem caudate [197], this model provides a potential link between repeat 
instability and cumulative damage as part of ageing and neurodegeneration. 
However, additional observations do not support a clear link between DNA oxidation 
and CAG instability; for example, oxidative lesions within the HTT CAG repeat tract 
itself were not age-dependent, nor did they correlate with tissue-specific instability in 
HD mice [183]. In support of this, the extent to which disease pathogenesis itself, 
including the dysregulation of DNA repair processes that occurs in HD [198–200] 
contributes to somatic CAG expansion is unclear. Rather, there is evidence to 
support the idea that the primary driver(s) of somatic CAG expansion are 
independent of disease manifestation. Indeed, mouse models for clinically distinct 
diseases show similar tissue-specific patterns of instability [87,109,115,201] and 
genetic and bioinformatic analyses in HttQ111 mice indicated that the susceptibility of 
a tissue to CAG expansion was independent of the ongoing pathogenic process [87]. 
Taken together, therefore, data provide support that the repair of oxidative DNA 
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lesions within the repeat tract can play a role in CAG instability but that they may not 
be necessary to drive expansion. 
 
Nucleotide Excision Repair Factors and transcription-based mechanisms 
 
Nucleotide excision repair (NER) removes bulky DNA lesions, including thymine 
dimers and 6-4 photoproducts [202]. The initial steps of NER differ depending on 
how the lesion is detected. In cycling cells, the global genome repair branch of NER 
(GG-NER) detects lesions and leads to the recruitment of TFIIH. By contrast, lesions 
in transcribed regions will activate the transcription-coupled branch of NER (TC-
NER) by causing the RNA polymerase to stall, CSB and CSA to be recruited, 
followed by TFIIH. The pathways merge with XPA binding to the lesion, followed by 
helicases and nucleases that remove 24-32 nucleotides around the lesion, leaving a 
DNA gap, which is filled by a DNA polymerase and ligated.  
TC-NER was first found to be involved in repeat instability in immortalized 
human HT1080 cells that harbored a selectable reporter system to monitor 
exclusively large contractions [67,68]. Knockdown of CSA, CSB, XPA, ERCC1, and 
XPG all reduced the frequency of large contractions in this system. In a Drosophila 
model of CAG/CTG intergenerational instability, a null allele in the XPG ortholog 
mus201 suppressed expansions and contractions [203]. It is worth pointing out that 
CAG instability in Drosophila models has not been shown to be dependent on MMR 
genes, raising the possibility that some of the mechanisms of instability in Drosophila 
may not be shared with mammalian systems. Subsequently, using a mouse model 
for spinocerebellar ataxia type 1 (SCA1), knockout of Xpa was shown to suppress 
somatic CAG expansion [108]. Surprisingly, Xpa knockout had a tissue-specific 
effect whereby, of the tissues analyzed, only the neuronal tissues had stabilized 
repeats [108]. In contrast to Xpa, knocking out Xpc, which is specifically involved in 
GG-NER, did not impact either somatic or intergenerational instability in HttQ111  mice 
[88]. This is consistent with the lack of impact of XPC knockdown in a selectable 
contraction-based reporter assay [67]. CSB was also implicated in repeat instability 
in R6/1 mice, but only had an effect on intergenerational instability, unless OGG1 
was also simultaneously knocked out [101], again suggesting possible cross-talk 
between DNA repair pathways. 
A role of TC-NER is in line with observations that transcription enhances 
CAG/CTG instability [67,203,204]. It is also notable that many NER proteins are part 
of the core transcription machinery [205]. In transgenic R6 mouse models with 
distinct sites of  transgene integration it was suggested that transcription is 
necessary for repeat instability [111]. However, transcription does not necessarily 
account for differences in instability of a particular repeat in different chromatin 
environments [121,124]. Further, steady state mRNA level does not correlate with 
tissue-specific instability across tissues [87,110,125], indicating a potentially more 
complex interaction between transcriptional state and instability. It was suggested 
that transcription elongation may better determine somatic expansion than 
transcription initiation in HD mouse models [182]. In support of this, transcription 
elongator factor TFIIS (TCEA2) promoted instability in cell-based assays [68,79], and 
downregulation of BRCA1/BARD1, a ubiquitin E3 ligase that regulates transcriptional 
elongation, suppressed instability [68]. Instability is also enhanced by bi-directional 
transcription through repeat tracts in cell-based models [71,204]. As disease-
associated repeats are transcribed in both sense and antisense directions (reviewed 
in [206]), this also provides a plausible mechanism by which transcription could 
modulate instability at endogenous repeat loci in patient cells or mouse models, 
though this remains to be tested.    
17 
 
Transcription through the repeat tract can also lead to R-loops, stable RNA-
DNA hybrids that form by annealing of the newly synthesized RNA transcript to the 
DNA template. They are favored by G-rich RNA and by secondary structure-forming 
sequences in the displaced single stranded DNA, such as CAG/CTG repeats 
[32,207–209]. R-loops are thought to be removed by either NER or dissolved by the 
action of RNase H enzymes. Indeed the latter have been implicated in large 
contractions in human cells, in which knockdown of RNAseH1 or RNaseH2A 
stimulated instability [71]. Moreover, in a cell-free system, human cell extracts from 
HeLa and SH-SY5Y cells could process R-loops, promoting repeat instability, an 
effect that was partially suppressed by treatment with RNase H [207,208]. In HT1080 
cells harboring 800 CTG repeats, knockdown of SETX (Senataxin), a putative 
RNA/DNA helicase with a function in resolving R-loops, stimulated repeat 
contractions [79]. Interestingly, R-loop mediated CAG/CTG repeat instability in S. 
cerevisiae was found to be dependent both on cytosine deamination and BER, and 
on MutLγ nuclease activity [210]. These studies suggest that there may be multiple 
pathways by which R-loops at CAG/CTG tracts can be processed.  
Although not thoroughly tested, transcription-based mechanisms are attractive 
in the context of post-mitotic neurons as transcription-associated repair of DNA 
lesions remains active in the absence of replication [211]. Potential intersection with 
R-loop biology, TC-NER, and other DNA repair pathways is an interesting area of 
further investigation.  
 
Roles of additional DNA repair or replication factors 
 
In contrast to the involvement of MMR, BER, and NER-related mechanisms in 
various aspects of CAG/CTG instability, there has been little support for a prominent 
role of double strand break (DSB) repair mechanisms in repeat instability in 
mammalian cells.  Although RAD51, involved in homologous recombination (HR), 
protected against large contractions [73], there was no impact of knocking out HR 
genes Rad54 and Rad52 on CTG somatic expansion in a DM1 mouse model [106]. 
Rad52, but not Rad54 knockout did increase the size of intergenerational 
expansions in this model, potentially implicating single-strand annealing (SSA) 
mechanism of DSB repair, in which RAD52 is also involved. Non-homologous end-
joining (NHEJ) is the most commonly used DSB repair pathway in mammals. This 
has not been studied in depth in the context of repeat instability, however knockout 
of NHEJ gene DNAPKcs had no impact on somatic or intergenerational instability in 
DM1 transgenic mice [106]. CTIP and MRE11, genes involved in the sensing and 
signaling of DSB repair, did not modify CAG expansion in a human selectable assay 
[76]. BRCA1, which enhanced contractions in a selectable assay [68], has diverse 
roles that include transcription, coordinating repair of DBSs, HR, as well as ICL 
repair [212]. Given the multifunctional nature of BRCA1, it is plausible that in the 
unusual context of expanded repeats, this protein might also intersect with other 
DNA repair mechanisms.   
Several modifier genes have been identified that influence CAG/CTG 
instability in the context of DNA replication. Replication-based mechanisms may be 
more important in rapidly dividing cells, including the germline and during early 
embryonic development. In human cells, the RTEL1 helicase blocked repeat 
expansions [74]. It is proposed to act via its hairpin unwinding activity, together with 
HLTF, a nucleosome remodeling factor and RAD18, an E3 ubiquitin ligase, both of 
which suppress expansions [74]. RTEL1 appears to be a functional homolog of the 
Srs2 helicase, originally found in S. cerevisiae to inhibit repeat expansion [213], and 
for which there are no sequence homologs in metazoans. It was proposed that 
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RTEL1/HLTF/RAD18 act to prevent repeat expansions during post-replication repair 
mechanisms that allow replication forks to progress through lesions on damaged 
templates [74]. In a HeLa cell-based model containing an ectopic integrated cassette 
that includes the c-myc replication origin and CAG/CTG repeats, as well as in DM1 
fibroblasts, knockdown of one of CLSPN, TIMELESS, or TIPIN, which all play a role 
in replication stress and fork stabilization, resulted in a substantial increase in repeat 
contractions [80]. Whether any of the factors that appear to sense or resolve 
CAG/CTG-mediated replication stress play a role in modulating somatic or 
intergenerational repeat instability in mouse models is unknown.  
 
Cis elements, chromatin, and post translational modifications in repeat 
instability 
 
Some instability modifiers provide insight into ways in which DNA metabolic 
processes that influence repeat instability might be regulated. In addition to factors 
that act in trans, there is evidence that the instability of CAG/CTG repeats can be 
modulated in cis by DNA elements other than repeat length, repeat sequence and 
purity (reviewed in [206,214]). For example, the expansion propensity of different 
disease-associated CAG/CTG repeats correlates with the GC-content of the flanking 
DNA [123,215,216]. Interestingly, there is an association between ancestral HTT 
haplotype and the mean length of the unexpanded CAG repeat, leading to the 
speculation that certain HTT haplotypes may be predisposed to CAG instability due 
to cis-acting elements [217]. In mouse models, the genomic contexts of transgenes 
or knock-in alleles can modulate instability [111,115,119,121,123–125]; notably, 
repeats flanked by genomic DNA are more unstable than those within cDNA 
transgenes [123,124]. Insights into the precise nature of the cis-factors and the 
mechanisms by which they modulate repeat instability are currently very limited. 
Chromatin context regulates DNA repair, transcription and replication [218–220], and 
chromatin marks, including trimethylation of histone H3 at Lys36 (H3K36me3), and 
chromatin-remodeling factors have recently been shown to regulate MMR (reviewed 
in [221]), indicating possible routes for modification of CAG instability in cis. 
Replication fork dynamics, which can influence instability, are also influenced by cis-
factors [222].  
Highly expanded trinucleotide repeats tend to be associated with epigenetic 
marks of heterochromatin such as DNA methylation and methylation of histone H3 at 
Lys9 (H3K9) (reviewed in [206]). Greater levels of DNA methylation at the DMPK 
CTG repeat locus were also found in tissues exhibiting greater somatic expansion 
[223]. Interestingly, disease-associated repeat loci were shown to localize to 
topology-associated domains (TAD) and subTAD chromatin boundaries [224]. CGG 
repeat expansion at the FMR1 locus disrupted this boundary [224]. However, in a 
different study, 4C sequencing of the HTT and DMPK loci did not identify any 
changes in chromatin structure in the presence of expanded repeats [225]. The 
extent to which local epigenetic changes associated with expanded repeats might 
themselves contribute to repeat instability is unknown. In model systems global 
demethylation destabilized repeats [147,226], and Dnmt1 deficiency promoted 
germline CAG instability in a mouse model of SCA1 [70]. In these cases, instability 
modification may be due to local DNA methylation changes, to the altered 
expression of other genes that modulate instability in trans, or both.  More direct 
evidence for a cis-modifier effect comes from SCA7 mouse models in which mutation 
of a CTCF binding site adjacent to the Atxn7 CAG repeat promoted instability in 
specific tissues, notably in the kidney [124]. A similarly high level of expansion in a 
kidney was observed in a mouse with a wild type, but methylated, CTCF binding site. 
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These results suggested a model in which CTCF protects against repeat expansion 
in a methylation-dependent manner [124]. 
Other proteins with chromatin-modifying activities also influence repeat 
instability. In a selectable assay for CAG expansions in cultured astrocytes, 
knockdown of histone deacetylase genes HDAC3 or HDAC5 suppressed 
expansions, whereas knockdown of histone acetyltransferase (HAT) gene CREBBP, 
encoding CREB-binding protein (CBP) or EP300, encoding the related P300 protein, 
promoted expansions [75,76]. Loss of CBP also promoted CAG expansions in the 
Drosophila germline [203]. These genetic data are supported by the suppression of 
instability upon treatment with the Class I/II HDAC inhibitor trichostatin A (TSA) 
[203]. Genetic knockout of either Hdac2 or Hdac3 in MSNs of HttQ111 knock-in mice 
moderately suppressed striatal expansions [91]. The impact of Hdac3 knockout in 
this model is consistent with the expansion-suppressing effect of a selective HDAC3 
inhibitor [227]. Relationships between HDACs, HATs and repeat instability appear to 
be complex, however. For example, knockdown of HDAC9 promoted, rather than 
suppressed, CAG expansion in the cultured astrocyte model [76], and HDAC 
inhibitors promoted contractions in a selectable human cell-based assay [91]. In S. 
cerevisiae, loss of function of different HDACs either enhanced or suppressed CAG 
instability [75,228], with CAG stability being dependent on activities of both HDACs 
and HATs that control levels of H4 acetylation [228]. As in the case of DNA 
methylation, HDACs or HATs may modify repeat instability via epigenetic changes in 
cis and/or by altering the expression or activity of trans-acting factors. A trans-
mediated effect was proposed to account for the impact of CBP loss in Drosophila 
[203]. In human astrocytes, epistasis experiments provided evidence that HDAC3 
and MSH2 act in a common pathway to promote expansion [76]. Further molecular 
experiments indicated that HDAC3 knockdown did not alter the binding of MutSβ at 
the repeat tract, or the expression level of MSH2 or MSH3, together suggesting an 
alternative hypothesis that HDAC3 modulates instability by regulating MSH2 or 
MSH3 acetylation. Indeed, activities of both MSH2 and MLH1 can be altered by 
acetylation [229–231], indicating that this is a plausible mechanism for instability 
modification by HDACs and HATs. Recent studies show that MSH3 peptides can be 
deacetylated by HDAC3 and that the nuclear localization of MSH3 is regulated by a 
selective HDAC3 inhibitor [232]. Roles of histone modification in cis contributing to 
instability have not been demonstrated directly in mammalian systems, however in 
S. cerevisiae a protective effect of chromatin remodeler Isw1 against CAG expansion 
during transcription could be attributed at least in part to a direct effect at the repeat 
tract as nucleosome occupancy over the CAG tract was altered in isw1 mutants 
[233].  
 
Cellular stressors in repeat instability 
 
Cellular stresses can also induce changes in repeat instability. DNA damaging 
agents could work by inducing damage to the repeat tract directly (see section 
below), indirectly causing cellular stress, or both. For instance, Gorbunova et al. 
[132] treated cells with hydroxyurea, which depletes dNTP pools and slows DNA 
replication, ionizing radiation, which causes DNA breaks, or aphidicolin, an inhibitor 
of DNA polymerase α. In this early example, these treatments induced large 
contractions, with unknown effects on expansions. Other studies in cell-based 
models have found effects on CAG/CTG instability of other DNA damaging 
compounds that include DNA intercalating agents, nucleoside analogues, and 
hydrogen peroxide [72,136,234]. These experiments can often be difficult to interpret 
due to effects of DNA damaging compounds on the cell cycle and potential clonal 
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selection that could artifactually alter the distribution of CAG-containing alleles in a 
population without modifying repeat instability. Other types of cellular stresses that 
alter repeat instability include cold and heat shock [135], and pharmacological and 
genetic suppression of the proteasome [68,77] or of HSP90 [73]. Cellular stressors 
could act indirectly by altering levels or activities of DNA repair proteins that control 
repeat instability and may provide a means to stimulate repeat instability to facilitate 
analyses in mammalian cell-based models where the natural time-course of somatic 
expansion is slow. 
 
Direct perturbation of the repeat tract 
  
Alternative routes to modifying repeat instability involve direct perturbation of the 
repeat tract. Of the small molecule studies conducted thus far 
[72,75,132,136,203,227,235,236],  only one compound has been shown to engage 
directly the repeat tract at the DNA level. Indeed, Nakamori et al. [236], found that 
naphthyridine-azaquinolone (NA) can bind to CAG loops, stabilize them, and induce 
contractions and/or prevent expansions in human cell culture as well as in the R6/2 
HD mouse model. Overall, there has been no small molecule that is non-toxic and 
efficiently prevents expansions or induces contractions at doses that are 
physiologically relevant. It will therefore be exciting to see whether NA can be turned 
into a viable therapeutic. Antisense oligonucleotides (ASOs) are being using in pre-
clinical and clinical settings to reduce the toxic huntingtin protein or the toxic DMPK 
mRNA [237–239]. Interestingly, an ASO against the repeat tract itself was seen to 
reduce repeat instability through a unknown mechanism, though direct binding to the 
repeat is one possibility [238]. 
Directly damaging the repeat tract, by inducing a DSB within or very near it 
has been used to induce instability in yeast and mammalian cells [81,130,134,240–
245]. These studies have shown that homologous recombination and the DNA 
damage response are both involved in generating repeat instability. It is not clear 
that the same modifiers that affect repeat instability in the absence of a direct assault 
on the repeat tract, will be involved in these more artificial systems. Indeed, as 
pointed out above, several factors involved in DSB repair do not seem to influence 
repeat instability in mammalian models [106]. Nevertheless, directly damaging 
repeats may be harnessed for gene editing and may therefore have therapeutic 
relevance.  
The first generation of customizable gene editing tools were Zinc Finger 
Nucleases (ZFNs). ZFNs consist of two FokI nuclease domains that must come 
together to induce a DSB at the target sequence [246]. Both halves are fused to 
customizable DNA binding domains, each targeting a DNA triplet. In the context of 
expanded repeats, they were first used in a chromosomal reporter assay that 
measures large contractions [245]. They led to a 14-fold increase in the number of 
contractions and induced rearrangements near the repeat tract. Another group, using 
expanded repeats inserted in the genome of HeLa cells, also found that they 
efficiently induced contractions [81]. Interestingly, in both studies, one of the two 
halves of the ZFN was shown to induce instability on its own. The first study 
suggested that one of the studies could not distinguish effectively between the CAG 
and CTG strands and thus cut both [245]. The authors of the second study rather 
postulated that the ZFN could cut out the secondary structures formed by the repeat 
tract, which led to the instability [81]. 
Transcription activator-like effectors (TALEs) were the basis for the second 
generation of programmable nucleases. They have the advantage that each DNA 
binding domain binds a specific base pair, making their design easier, although 
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repetitive [247,248]. Fusing the FokI nuclease to them as with the ZFNs allows for 
precise induction of a DSB in the human genome [249]. TALENs have been used 
against expanded CAG/CTG repeats in yeast to great effect [240,241], but they are 
yet to be tried in mammalian systems.   
CRISPR was discovered in 2012 and it has become the tool of choice for 
gene editing [250]. There are two major advantages of the CRISPR systems over 
other programmable nucleases. One is efficiency, the other is the ease of design. 
Indeed, Cas9, a nuclease, is guided to a sequence of choice using a single guide 
RNA (sgRNA) that contains a target sequence of choice [250,251]. The most widely 
used Cas9, from Staphylococcus pyogenes, requires a protospacer adjacent motif 
(PAM) composed of three nucleotides, NGG, where N is any nucleotide, required 
abutting the target sequence [252]. Thus, any sequence in the genome that abuts a 
usable PAM can be targeted and cut. Cas9, directed to the repeat tract itself, has 
been used to induce DSBs within the repeat tract in the context of a chromosomal 
reporter [134]. This led to a modest amount of expansions and contractions in 
roughly equal proportion, perhaps due to the suboptimal CAG and CTG PAMs. 
Interestingly, inducing a DSB near, but not within, the repeat tract led to a large 
increase in repeat instability, including expansions, contractions, and 
rearrangements, in immortalized mouse myoblasts from a transgenic DM1 mouse 
model containing 500 CTG repeats [253] as well as in yeast [254]. Together, studies 
inducing DSBs within the repeat tract suggest that they cause both expansions and 
contractions as well as larger rearrangements near the repeat tract. 
The use of the CRISPR system is ideal to test whether different types of DNA 
damage induced within the repeat tract could lead to changes in repeat instability. 
This was tried by Cinesi et al. using a D10A mutant of the Cas9 enzyme [134]. This 
mutation turns Cas9 into a nickase, which cuts only one of the two strands of DNA, 
i.e., it introduces nicks. In this case, the same sgRNA was used targeting the 
CAG/CTG repeat itself, enabling the comparison between DSBs and nicks. 
Surprisingly, the nickase induced predominantly contractions of the repeat tract, with 
up to a third of the cells having a contraction after 12 days of treatment. There were 
no rearrangements seen beyond those observed in the untreated population. 
Moreover, the effect of the nickase was repeat length-dependent with mildly 
expanded or short alleles not being targeted. In line with this, the number of off-
target mutations at other endogenous, non-pathogenic, CAG/CTG repeat loci was 
below the detection level of the assay used [134]. The nickase remains to be tested 
in other systems, however. 
 
Conclusions and perspectives 
 
Through a variety of approaches and model systems considerable progress has 
been made in delineating factors that can modify the instability of CAG/CTG repeats. 
These include DNA repair proteins that act in pathways to enhance or suppress 
instability and reagents that interact directly with the repeat tract. Emerging data hint 
at possible mechanisms by which DNA repair pathways might be regulated, for 
example through interaction with cis-elements or by altering levels of DNA repair 
proteins or their activity, e.g., via post-translational modification. This is an interesting 
area of future investigation. Means by which repeat instability could be modulated 
are summarized in Figure 4, indicating plausible routes for therapeutic intervention. 
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Figure 4: Potential mechanisms for instability modifiers. Genetic or pharmacological manipulation can 
directly alter the level of activity of a DNA repair protein (1). Indirect effects are also possible via a 
regulatory factor that controls DNA repair gene expression, stability or activity (2), e.g. altering a 
posttranslational modification (PTM), or via interaction with a cis-element (3). The repeat can also be 
modified by agents that directly interact with the repeat (4).  
 
The mechanism(s) underlying repeat instability, however, remain poorly 
understood, but they are important to delineate in order to refine therapeutic 
approaches. For example, if DNA repair proteins act in non-canonical ways to modify 
repeat instability, this may provide opportunities for interventions that specifically 
target the repeat instability mechanism, whilst minimizing the impact on DNA repair 
processes more globally. Relatively few of the modifiers uncovered in simpler cell-
based assays have been tested in mouse models, and their significance in human 
disease is unclear. Although a process dependent on MMR genes is clearly critical 
for somatic CAG/CTG expansion in mouse models, potential intersections with 
factors in other DNA repair pathways such as BER or NER are not well understood. 
We highlight several questions and approaches to be addressed in future work.  
First, how do mechanisms of instability differ between cell types, for example 
between the germline and soma, or between the brain and periphery? A number of 
studies indicate that mechanisms may not be the same 
[57,70,88,92,100,101,105,106,108,255], and although many proteins function in 
repeat instability across cell types, factors may be specifically or preferentially 
involved, in a cell type-dependent manner. Several factors have been proposed to 
contribute to the tissue/cell type-specificity patterns of somatic expansion (reviewed 
in [109]), however the molecular underpinnings are unknown. Understanding the 
nature of these intrinsic cell type-specific instability drivers will also provide clues to 
underlying mechanisms. Differences in mechanism between post-mitotic and 
dividing cells are also likely, and in the germline where instability can arise at 
multiple stages during spermatogenesis in humans [6], processes in both dividing 
and non-dividing cells may be relevant. Second, although much has been learned 
about factors involved in somatic expansion, we know surprisingly little about repeat 
contraction. This is a significant question to address as promoting repeat contraction 
would clearly be an important therapeutic goal. Third, the majority of the genetic 
studies in model systems involve the knockdown or knockout of specific genes. 
Mechanistic insight will be enhanced by further studying the impact of functional 
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variation, for example to test the roles of enzymatic activities of DNA repair proteins 
[78,82,95]. Of particular significance are the functional variants discovered though 
human GWAS that will inform on ways in which instability can be modulated that, by 
definition, would be predicted to have an impact in patients. Fourth, what are the 
substrate(s) recognized by the DNA repair machinery in vivo? For example, is the 
substrate for MMR proteins simply an insertion loop that is recognized by the MutSβ 
complex in the same way this complex would recognize any other insertion loop, or 
does MutSβ interact with a CAG/CTG substrate in a distinct manner? Finally, there is 
currently a lack of connection between biochemical assays that are conducted in cell 
free systems and instability that occurs within cells. Developing systems to bridge 
this gap that would enable structure/function studies would be of value.  
Novel and emerging technologies, including CRISPR-based systems, single 
cell analyses and next-generation sequencing will enable the development of 
additional platforms for modifier screening/testing and a more comprehensive 
knowledge of the pathways and mechanisms that control repeat dynamics. Further, 
as current methods provide a steady state snapshot of repeat instability, innovative 
methodologies, including computational modeling, will be needed to capture the 
dynamic nature of the unstable repeats [256,257]. Ultimately, a greater 
understanding of repeat instability will provide additional therapeutic avenues in HD, 
DM1, and other repeat expansion disorders.   
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